Blood Banking (nvCJD)

New FDA Guidelines May Affect Blood Supply in Y2K

Published in Medical Letter on the CDC and FDA, September 6th, 1999

The recently issued U.S. Food and Drug Administration (FDA) guidelines on Creutzfeldt-Jakob Disease (CJD) and new variant CJD (nvCJD) may contribute to a serious blood shortage in the year 2000.

On August 17, 1999, the FDA issued a guidance as a precautionary measure in which blood centers were asked to exclude potential donors who have spent six or more cumulative months in the United Kingdom between January 1, 1980, and December 31, 1996.

Blood collection centers in the United States are expected to implement the new guidance over the next six months, which means that by February 17, 2000, all centers will have implemented the deferral...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1999-09-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry